The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Role of IL-6 trans-signaling in CCl4 induced liver damage
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Blockade of IL-6 trans-signaling by sgp130-Fc treatment worsened C-C motif ligand 4 (CCL4)-induced liver damage (Gewiese-Rabsch et al., 2010”
From Targeting Interleukin-6 Signaling in Clinic (2019) · cites this paper as Gewiese-Rabsch et al., 2010
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., & Taub, R. (2000) · Hepatology · doi:10.1002/hep.510310123 · Cited by 298
Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration
Peters, M., Blinn, G., Jostock, T., Schirmacher, P., Büschenfelde, K. M. Z., Galle, P. R., & Rose–John, S. (2000) · Gastroenterology · doi:10.1053/gast.2000.20236 · Cited by 129
Self-citationGalun, E., Zeira, E., Pappo, O., Peters, M., & Rose-John, S. (2000) · The FASEB Journal · doi:10.1096/fj.99-0913com · Cited by 124
Self-citation
Flagged first, then by citations
Research works printed but not linked: 29
- Rose-John, 1994, Biochem. J., 300, 281, 10.1042/bj3000281 · DOI
- Rose-John, 2006, J. Leuk. Biol., 80, 227, 10.1189/jlb.1105674 · DOI
- Sakamoto, 1999, Hepatology, 29, 403, 10.1002/hep.510290244 · DOI · Paper page
- Fischer, 1997, Nat. Biotechnol., 15, 145-5, 10.1038/nbt0297-142 · DOI
- Hecht, 2001, Mol. Therap., 3, 683, 10.1006/mthe.2001.0313 · DOI
- Jostock, 2001, Eur. J. Biochem., 268, 160, 10.1046/j.1432-1327.2001.01867.x · DOI
- Atreya, 2000, Nat. Med., 6, 583, 10.1038/75068 · DOI · Paper page
- Nowell, 2009, J. Immunol., 182, 613, 10.4049/jimmunol.182.1.613 · DOI · Paper page
- Becker, 2004, Immunity, 21, 491, 10.1016/j.immuni.2004.07.020 · DOI · Paper page
- Drucker, 2009, J. Interf. Cyt. Res., 29, 711, 10.1089/jir.2008.0095 · DOI
- Berger, 1986, Hepatology, 6, 36, 10.1002/hep.1840060108 · DOI
- Recknagel, 1989, Pharmacol. Ther., 43, 139, 10.1016/0163-7258(89)90050-8 · DOI
- Gutteridge, 1990, Trends Biochem. Sci., 15, 129, 10.1016/0968-0004(90)90206-Q · DOI
- Weber, 2003, Crit. Rev. Toxicol., 33, 105, 10.1080/713611034 · DOI
- Simeonova, 2001, Toxicol. Appl. Pharmacol., 177, 112, 10.1006/taap.2001.9304 · DOI
- Katz, 1998, Cytokines Cell. Mol. Ther., 4, 221
- Rabe, 2008, Blood, 111, 1021, 10.1182/blood-2007-07-102137 · DOI
- Buege, 1978, Meth. Enzymol., 52, 302, 10.1016/S0076-6879(78)52032-6 · DOI
- Chalaris, 2007, Blood, 110, 1748, 10.1182/blood-2007-01-067918 · DOI
- Becker, 1993, Free Radic. Biol. Med., 14, 615, 10.1016/0891-5849(93)90143-I · DOI
- Horiguchi, 2010, Hepatology, 51, 1724, 10.1002/hep.23532 · DOI
- Ohta, 2006, J. Appl. Toxicol., 26, 178, 10.1002/jat.1122 · DOI
- Albano, 1989, Biochem. Pharmacol., 38, 2719, 10.1016/0006-2952(89)90559-5 · DOI
- Kodavanti, 1991, Hepatology, 13, 230
- Rose-John, 2007, Expert Opin. Ther. Targets, 11, 613, 10.1517/14728222.11.5.613 · DOI
- Nishimoto, 2008, Blood, 112, 3959, 10.1182/blood-2008-05-155846 · DOI
- Frei, 1988, Proc. Natl Acad. Sci. USA, 85, 9748, 10.1073/pnas.85.24.9748 · DOI
- Nechemia-Arbely, 2008, J. Am. Soc. Nephrol., 19, 1106, 10.1681/ASN.2007070744 · DOI
- Wang, 2010, Hepatology, 51, 1354, 10.1002/hep.23430 · DOI
Cited by
Sorted by citations
IL-6 pathway in the liver: From physiopathology to therapy
Schmidt-Arras, D., & Rose-John, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.004 · Cited by 881
Self-citationTargeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology
Giraldez, M. D., Carneros, D., Garbers, C., Rose-John, S., & Bustos, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00473-x · Cited by 156
Self-citationInterleukin-6 Mediates Angiotensinogen Gene Expression during Liver Regeneration
Lai, H.-S., Lin, W.-H., Lai, S.-L., Lin, H.-Y., Hsu, W.-M., Chou, C.-H., & Lee, P.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067868 · Cited by 36
The Regenerative Activity of Interleukin-6
Galun, E., & Rose-John, S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-308-4_4 · Cited by 34
Self-citation
Metadata
- Authors
- Gewiese-Rabsch, J., Drucker, C., Malchow, S., Scheller, J., & Rose-John, S.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 1802
- Issue
- 11
- Pages
- 1054-1061
- ISSN
- 0925-4439
- Cited by
- 36
- References
- 4
- Language
- en
- Licence
- Funders
- Deutsche Forschungsgemeinschaft (SFB841)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review